{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:51:10Z","timestamp":1790182270595,"version":"4.1.0"},"reference-count":39,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1554,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1002\/art.30309","type":"journal-article","created":{"date-parts":[[2011,2,26]],"date-time":"2011-02-26T16:00:39Z","timestamp":1298736039000},"page":"1658-1667","source":"Crossref","is-referenced-by-count":82,"title":["Human mesenchymal stem cells inhibit osteoclastogenesis through osteoprotegerin production"],"prefix":"10.1002","volume":"63","author":[{"given":"Koichi","family":"Oshita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Yamaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Udagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Fukuyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koshiro","family":"Sonomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Maeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiya","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,5,31]]},"reference":[{"key":"10.1002\/art.30309-BIB1|cit1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrrheum.2009.217","article-title":"Osteoimmunology and the effects of the immune system on bone","volume":"5","author":"Takayanagi","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1002\/art.30309-BIB2|cit2","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P","article-title":"Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor","volume":"43","author":"Gravallese","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30309-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1359\/jbmr.090320","article-title":"Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis","volume":"24","author":"Walsh","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1002\/art.30309-BIB4|cit4","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s10165-008-0026-3","article-title":"Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year clinical outcomes (RECONFIRM-2)","volume":"18","author":"Tanaka","year":"2008","journal-title":"Mod Rheumatol"},{"key":"10.1002\/art.30309-BIB5|cit5","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(08)60453-5","article-title":"Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial","volume":"371","author":"Smolen","year":"2008","journal-title":"Lancet"},{"key":"10.1002\/art.30309-BIB6|cit6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10165-008-0077-5","article-title":"Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year outcome of joint destruction (RECONFIRM-2J)","volume":"18","author":"Takeuchi","year":"2008","journal-title":"Mod Rheumatol"},{"key":"10.1002\/art.30309-BIB7|cit7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"10.1002\/art.30309-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"10.1002\/art.30309-BIB9|cit9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11373-004-8183-7","article-title":"T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression","volume":"12","author":"Klyushnenkova","year":"2005","journal-title":"J Biomed Sci"},{"key":"10.1002\/art.30309-BIB10|cit10","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1182\/blood-2004-02-0586","article-title":"Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells","volume":"105","author":"Jiang","year":"2005","journal-title":"Blood"},{"key":"10.1002\/art.30309-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1182\/blood-2007-02-074997","article-title":"Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2","volume":"111","author":"Spaggiari","year":"2008","journal-title":"Blood"},{"key":"10.1002\/art.30309-BIB12|cit12","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.4049\/jimmunol.0803962","article-title":"Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner","volume":"182","author":"Rafei","year":"2009","journal-title":"J Immunol"},{"key":"10.1002\/art.30309-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2005-04-1496","article-title":"Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy","volume":"106","author":"Zappia","year":"2005","journal-title":"Blood"},{"key":"10.1002\/art.30309-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/jcb.20886","article-title":"Mesenchymal stem cells as trophic mediators","volume":"98","author":"Caplan","year":"2006","journal-title":"J Cell Biochem"},{"key":"10.1002\/art.30309-BIB15|cit15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/path.2469","article-title":"Why are MSCs therapeutic? New data: new insight","volume":"217","author":"Caplan","year":"2009","journal-title":"J Pathol"},{"key":"10.1002\/art.30309-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"LeBlanc","year":"2008","journal-title":"Lancet"},{"key":"10.1002\/art.30309-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/art.23417","article-title":"Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial","volume":"58","author":"Cohen","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30309-BIB18|cit18","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrrheum.2009.104","article-title":"Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases","volume":"5","author":"Djouad","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1002\/art.30309-BIB19|cit19","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.CIR.0000114522.38265.61","article-title":"Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives","volume":"109","author":"Planat-Benard","year":"2004","journal-title":"Circulation"},{"key":"10.1002\/art.30309-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1080\/10428190701361869","article-title":"Multipotent mesenchymal stromal cells and immune tolerance","volume":"48","author":"Noel","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1002\/art.30309-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/art.22511","article-title":"Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis","volume":"56","author":"Augello","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30309-BIB22|cit22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.1621100","article-title":"Increased osteoclast development after estrogen loss: mediation by interleukin-6","volume":"257","author":"Jilka","year":"1992","journal-title":"Science"},{"key":"10.1002\/art.30309-BIB23|cit23","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/jbmr.5650110113","article-title":"Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation","volume":"11","author":"Kotake","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1002\/art.30309-BIB24|cit24","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1002\/art.22175","article-title":"Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system","volume":"54","author":"De Benedetti","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30309-BIB25|cit25","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1210\/en.2007-1719","article-title":"Interleukin-6 inhibits receptor activator of nuclear factor \u03baB ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: key role of serine727 phosphorylation of signal transducer and activator of transcription 3","volume":"149","author":"Duplomb","year":"2008","journal-title":"Endocrinology"},{"key":"10.1002\/art.30309-BIB26|cit26","doi-asserted-by":"crossref","first-page":"11535","DOI":"10.1074\/jbc.M607999200","article-title":"Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-\u03baB signaling pathways","volume":"283","author":"Yoshitake","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1002\/art.30309-BIB27|cit27","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.1210\/en.2005-0451","article-title":"Prostaglandin E2 strongly inhibits human osteoclast formation","volume":"146","author":"Take","year":"2005","journal-title":"Endocrinology"},{"key":"10.1002\/art.30309-BIB28|cit28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3858\/emm.2009.41.5.035","article-title":"Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10","volume":"41","author":"Yang","year":"2009","journal-title":"Exp Mol Med"},{"key":"10.1002\/art.30309-BIB29|cit29","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.4049\/jimmunol.0804165","article-title":"IL-10 suppresses calcium-mediated costimulation of receptor activator NF-\u03baB signaling during human osteoclast differentiation by inhibiting TREM-2 expression","volume":"183","author":"Park-Min","year":"2009","journal-title":"J Immunol"},{"key":"10.1002\/art.30309-BIB30|cit30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1182\/blood-2006-02-002246","article-title":"Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells","volume":"109","author":"Sato","year":"2007","journal-title":"Blood"},{"key":"10.1002\/art.30309-BIB31|cit31","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1210\/en.141.9.3478","article-title":"Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function","volume":"141","author":"Udagawa","year":"2000","journal-title":"Endocrinology"},{"key":"10.1002\/art.30309-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev"},{"key":"10.1002\/art.30309-BIB33|cit33","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1006\/bbrc.1998.8697","article-title":"Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor osteoprotegerin","volume":"247","author":"Mizuno","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1002\/art.30309-BIB34|cit34","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1084\/jem.192.4.463","article-title":"Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis","volume":"192","author":"Min","year":"2000","journal-title":"J Exp Med"},{"key":"10.1002\/art.30309-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0002-9440(10)64417-3","article-title":"Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis","volume":"161","author":"Romas","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1002\/art.30309-BIB36|cit36","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","article-title":"Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand","volume":"402","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1002\/art.30309-BIB37|cit37","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1210\/en.140.8.3736","article-title":"Human mesenchymal stem cells promote human osteoclast differentiation from CD34+ bone marrow hematopoietic progenitors","volume":"140","author":"Mbalaviele","year":"1999","journal-title":"Endocrinology"},{"key":"10.1002\/art.30309-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S8756-3282(02)00915-8","article-title":"Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism","volume":"32","author":"Kudo","year":"2003","journal-title":"Bone"},{"key":"10.1002\/art.30309-BIB39|cit39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1475-2867-9-26","article-title":"Therapeutic implications of osteoprotegerin","volume":"9","author":"Fili","year":"2009","journal-title":"Cancer Cell Int"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.30309","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/art.30309\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T21:36:39Z","timestamp":1625088999000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.30309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,31]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"URL":"https:\/\/doi.org\/10.1002\/art.30309","relation":{},"ISSN":["0004-3591"],"issn-type":[{"value":"0004-3591","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5,31]]}}}